120 related articles for article (PubMed ID: 22232715)
1. Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population.
Hong IK; Eun YG; Chung DH; Kwon KH; Kim DY
Clin Exp Otorhinolaryngol; 2011 Dec; 4(4):193-8. PubMed ID: 22232715
[TBL] [Abstract][Full Text] [Related]
2. The role of oncostatin M receptor gene polymorphisms in bladder cancer.
Deng S; He SY; Zhao P; Zhang P
World J Surg Oncol; 2019 Feb; 17(1):30. PubMed ID: 30755233
[TBL] [Abstract][Full Text] [Related]
3. [Association of OSMR gene polymorphisms with dilated cardiomyopathy in a Han Chinese population].
Dai X; Peng Y; Zhou B; Li C; Song H; Dou Q; Xie X; Rao L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):210-214. PubMed ID: 29652994
[TBL] [Abstract][Full Text] [Related]
4. Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population.
Kim SW; Kim CD; Chung JH; Kwon KH
Clin Exp Otorhinolaryngol; 2014 Mar; 7(1):42-6. PubMed ID: 24587880
[TBL] [Abstract][Full Text] [Related]
5. A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population.
Kim SK; Kim DK; Oh IH; Song JY; Kwon KH; Choe BK; Kim YH
J Korean Surg Soc; 2011 Nov; 81(5):308-15. PubMed ID: 22148122
[TBL] [Abstract][Full Text] [Related]
6. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
7. Association of oncostatin M receptor polymorphisms with clinical recurrence of ovarian cancer in the Chinese Han population.
Li Q; Wang Y; Li Z; Su M; Song Y; Hu Q; Zhou B; Zhang L
Biomark Med; 2022 Apr; 16(6):461-471. PubMed ID: 35321549
[No Abstract] [Full Text] [Related]
8. Interleukin 22 polymorphisms and papillary thyroid cancer.
Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
[TBL] [Abstract][Full Text] [Related]
9. A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer.
Han SA; Song JY; Min SY; Park WS; Kim MJ; Chung JH; Kwon KH
Exp Ther Med; 2012 Sep; 4(3):519-523. PubMed ID: 23181129
[TBL] [Abstract][Full Text] [Related]
10. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
[TBL] [Abstract][Full Text] [Related]
11. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.
Kwon KH; Lee YC; Chung JH; Eun YG
J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
[TBL] [Abstract][Full Text] [Related]
13. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
14. A Polymorphism (rs1801018, Thr7Thr) of BCL2 is Associated with Papillary Thyroid Cancer in Korean Population.
Eun YG; Hong IK; Kim SK; Park HK; Kwon S; Chung DH; Kwon KH
Clin Exp Otorhinolaryngol; 2011 Sep; 4(3):149-54. PubMed ID: 21949582
[TBL] [Abstract][Full Text] [Related]
15. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
[TBL] [Abstract][Full Text] [Related]
16. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
[TBL] [Abstract][Full Text] [Related]
17. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in bone morphogenetic protein 3 and the risk of papillary thyroid cancer.
Kim YO; Hong IK; Eun YG; Nah SS; Lee S; Heo SH; Kim HK; Song HY; Kim HJ
Oncol Lett; 2013 Jan; 5(1):336-340. PubMed ID: 23255945
[TBL] [Abstract][Full Text] [Related]
19. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
Eun YG; Kim SK; Chung JH; Kwon KH
Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma.
Ban JY; Kim MK; Park SW; Kwon KH
Immunol Invest; 2012; 41(8):888-905. PubMed ID: 23215728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
